Integral imaging reconstruction system based on the human eye viewing mechanism.

For integral stereo imaging systems based on lens arrays, the cross-mixing of erroneous light rays between adjacent lenses seriously affects the quality of the reconstructed light field. In this paper, we proposed a light field reconstruction method based on the human eye viewing mechanism, which incorporates simplified human eye imaging into the integral imaging system. First, the light field model for specified viewpoint is established, and the distribution of the light source for each viewpoint is accurately calculated for the EIA generation algorithm of fixed viewpoint. Second, according to the ray tracing algorithm in this paper, non-overlapping EIA based on the human eye viewing mechanism is designed to suppress the amount of crosstalk rays fundamentally. The actual viewing clarity is improved with the same reconstructed resolution. Experimental results verify the effectiveness of the proposed method. The SSIM value is higher than 0.93, which verifies that the viewing angle range is increased to 62°.

Clinical practice guidelines for the nutritional risk screening and assessment of cancer patients: a systematic quality appraisal using the AGREE II instrument.

PURPOSE: To evaluate the quality of published clinical practice guidelines (CPGs) regarding the nutritional risk screening and assessment of cancer patients and to identify high-quality CPGs for clinical healthcare professionals. METHODS: Guidelines for the nutritional risk screening and assessment of cancer patients were comprehensively searched in eight electronic databases, including The Lancet, PubMed, Cochrane Library, Excerpta Medica dataBASE (EMBASE), Web of Science, China National Knowledge Infrastructure (CNKI), China Biology Medicine disc (CBMdisc), and Wan Fang Data, through August 2020. Six relevant guideline databases, including the National Comprehensive Cancer Network (NCCN), the National Guideline Clearinghouse (NGC), the Guideline International Network (GIN), the New Zealand Guidelines Group (NZGG), the China Guideline Clearinghouse (CGC), and Medlive, and relevant nutrition society websites, were also searched through August 2020. The methodological quality of the included CPGs was appraised independently by three assessors using the Appraisal of Guidelines for Research and Evaluation, 2nd edition (AGREE II) tool. RESULTS: Seven CPGs were located, and the domain with the highest percentage was "clarity of presentation" (85.44%), while the domain with the lowest percentage was "applicability" (40.26%). From the AGREE II results, two guidelines were rated as "strongly recommended," three were assessed as "recommended with modifications," and two were deemed as "not recommended." CONCLUSION: Considering that the two "strongly recommended" guidelines were developed within the American and European contexts, translation, validation, and cultural adaptation are recommended prior to implementing these guidelines in other countries or healthcare contexts to improve their effectiveness and sensitivity for local cancer patients. TRIAL REGISTRATION: PROSPERO registration of the study protocol: CRD42020177390 (July 5, 2020).